---
title: 'The implementation and side effect management of immune checkpoint inhibitors
  in gynecologic oncology: a JAGO/NOGGO survey'
date: '2025-01-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39881252/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250130170945&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: The results of this survey provide valuable insights into
  physicians'' real-world experiences with irAEs associated with ICI treatment. Dealing
  with serious immune-related and potentially life-threatening side effects has become
  a routine aspect of clinical practice. Many physicians, however, express a lack
  of sufficient familiarity with irAEs and their management. Therefore, it is essential
  to improve medical education, specialized oncological training, and close ...'
disable_comments: true
---
CONCLUSION: The results of this survey provide valuable insights into physicians' real-world experiences with irAEs associated with ICI treatment. Dealing with serious immune-related and potentially life-threatening side effects has become a routine aspect of clinical practice. Many physicians, however, express a lack of sufficient familiarity with irAEs and their management. Therefore, it is essential to improve medical education, specialized oncological training, and close ...